Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

“Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis” Alexandra M. Nanzer, Jaideep Dhariwal, Joanne Kavanagh, Andrew Hearn, Mariana Fernandes, Louise Thomson, Cris Roxas, Linda Green, Grainne D'Ancona, Sangita Agarwal, Brian D. Kent and David J. Jackson. ERJ Open Res 2019; 6: 00272-2019

ERJ Open Research 2021 7: 50451-2020; DOI: 10.1183/23120541.50451-2020
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article was originally published with an error in the vertical axis labels of figure 1c. The corrected caption is shown below, and the article has been corrected and republished online.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Reduction from baseline to 48 weeks in a) maintenance oral corticosteroid (mOCS) dose (p=0.0018), b) Birmingham Vasculitis Activity Score (BVAS) (p=0.0007) and c) Asthma Control Questionnaire score (ACQ) (p=0.012). Data are presented as a) median (interquartile range) and b and c) mean±sd.

  • ©The authors 2021
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

PreviousNext
Back to top
Vol 7 Issue 1 Table of Contents
ERJ Open Research: 7 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
“Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis” Alexandra M. Nanzer, Jaideep Dhariwal, Joanne Kavanagh, Andrew Hearn, Mariana Fernandes, Louise Thomson, Cris Roxas, Linda Green, Grainne D'Ancona, S…
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
“Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis” Alexandra M. Nanzer, Jaideep Dhariwal, Joanne Kavanagh, Andrew Hearn, Mariana Fernandes, Louise Thomson, Cris Roxas, Linda Green, Grainne D'Ancona, Sangita Agarwal, Brian D. Kent and David J. Jackson. ERJ Open Res 2019; 6: 00272-2019
ERJ Open Research Jan 2021, 7 (1) 50451-2020; DOI: 10.1183/23120541.50451-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
“Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis” Alexandra M. Nanzer, Jaideep Dhariwal, Joanne Kavanagh, Andrew Hearn, Mariana Fernandes, Louise Thomson, Cris Roxas, Linda Green, Grainne D'Ancona, Sangita Agarwal, Brian D. Kent and David J. Jackson. ERJ Open Res 2019; 6: 00272-2019
ERJ Open Research Jan 2021, 7 (1) 50451-2020; DOI: 10.1183/23120541.50451-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • “An adaptation strategy to urban heat: hospital rooms with radiant cooling accelerate patient recovery”. Christina Hoffmann, Uta Liebers, Philipp Humbsch, Marija Drozdek, Georg Bölke, Peter Hoffmann, Adrien Holzgreve, Gavin C. Donaldson and Christian Witt. ERJ Open Res 2021; 7: 00881-2020.
  • “Lung volume reduction in emphysema: a pragmatic prospective cohort study”. Christophe Dooms, Astrid Blondeel, Laurens J. Ceulemans, Johan Coolen, Stephanie Everaerts, Heleen Demeyer, Thierry Troosters Geert Verleden, Dirk Van Raemdonck and Wim Janssens. ERJ Open Res 2021; 7: 00877-2020
  • “Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study” Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu and Demosthenes Bouros. ERJ Open Res 2020; 6: 00152-2020.
Show more Erratum

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2022 by the European Respiratory Society